Global Bipolar Disorder Market Trends, Size, Forecast - 2019-2025

The global bipolar disorder market is growing at a significant CAGR of around 2.7% during the forecast period (2019-2025). The major factors that are primarily driving the growth of the market include the increased workplace stress, emerging awareness regarding the management of mental disorders, and growing insurance claims for mental health. According to the World Health Organization (WHO), almost 83 million people are affected annually by mental disorders among the adult population of Europe (aged 18-65), where female rates are higher than males. This involves the high demand for products which can bring down the level of stress and bipolar disorder among people. In addition, there are various organizations and educational institutions such as ALAS Pro Salud Mental and Stanford University that have taken immense steps to spread awareness programs. These programs are assisting individuals to notice behavior change and other stress-related symptoms in their daily lives on accounts of which the demand for bipolar disorder treatment is increasing.

Request a free sample of our report on Global Bipolar Disorder Market : https://www.omrglobal.com/request-sample/bipolar-disorder-market

Additionally, there are bipolar disorder management apps available in the market, which include T2 mood tracker and eMoods. These apps are based on cognitive-behavioral therapy and are designed to address bipolar disorder at a gradual pace and offer ways for the appropriate management of stress. For instance, MoodTracker.com is a simple web app that enables to track key health measurements, such as water intake, anxiety levels, depression, and sleep, among others. It maintains track of medications, exercises, and supplements and allows tracking any change in the treatment with complete history. It supports depressed and bipolar users to manage their condition with careful journaling and tracking their moods.

A full report of Global Bipolar Disorder Market is available at : https://www.omrglobal.com/industry-reports/bipolar-disorder-market

Global Bipolar Disorder Market Segmentation

By Type
• Bipolar Disorder I
• Bipolar Disorder II
• Others (Cyclothymic Disorder)

By Treatment
• Drugs & Medications
o Anticonvulsants
o Antidepressants
o Antipsychotics
o Others (Mood Stabilisers)

• Therapy & Devices/Apps

By Mechanism of Action

• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
• Benzodiazepines
• Beta Blockers
• Others (Tricyclic Antidepressants (TCAs))

Regional Analysis

• North America
o United States
o Canada

• Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe

• Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific

• Rest of the World

Company Profiles
• Abbott Laboratories
• AbbVie Inc.
• Alkermes PLC
• Allergan PLC
• AstraZeneca PLC
• Brainsway Ltd.
• Bristol-Myers Squibb Co.
• Eli Lilly and Co.
• GlaxoSmithKline PLC
• H. Lundbeck A/S

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/bipolar-disorder-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.